James L. Sherley graduated from Harvard College in 1980 with a B.A. degree in biology; and he completed joint M.D. and Ph.D. degrees at the Johns Hopkins University School of Medicine in 1988. After post-doctoral studies in cancer cell molecular biology at Princeton University, he joined the Fox Chase Cancer Center as a principal investigator in 1991. In 1998, he joined the faculty of the future Department of Biological Engineering at Massachusetts Institute of Technology, where he undertook research and teaching in the areas of cancer cell molecular biology, tissue stem cell bioengineering, toxicology, and environmental health science until moving to Boston Biomedical Research Institute (BBRI) in 2007. As a Senior Member of BBRI’s research programs in Regenerative Biology and Cancer Biology, Dr. Sherley established an academic center for developing adult stem cell-based technologies for advancing cellular medicine. After leaving BBRI, in October 2013 he founded Asymmetrex, LLC, which he now directs as President and CEO. Asymmetrex has the mission of advancing technologies for stem cell medicine. The company recently developed the first method of determining the dosage of therapeutic adult stem cells. Dr. Sherley’s awards include 1993 Pew Biomedical Research Scholar, 2003 Ellison Medical Foundation Senior Scholar in Aging Research, and 2006 NIH Director’s Pioneer Award. He is also “PGP-10” in the Personal Genome Project at Harvard Medical School.
James L. Sherley, M.D., Ph.D.
Latest Research & News
Update: COVID-19 Vaccine Candidates and Abortion-Derived Cell Lines | September 30, 2020
To view this chart as a PDF, see: COVID-19 Vaccine Candidates and Abortion-Derived Cell Lines Updated June 2, 2021 Accurate information about the development and production of COVID-19 vaccines is essential, especially because many proposed candidates use newer molecular technologies for production of a viral vaccine. One concern regarding the ethical assessment of […]
A Visual Aid to Viral Infection and Vaccine Production | June 15, 2020
This is Issue 1 in CLI’s On Science. To view this report as a PDF, see: A Visual Aid to Viral Infection and Vaccine Production Updated November 2020 Introduction As a result of the rapid spread of the new coronavirus technically known as SARS-CoV-2, the United States and other governments have begun crash […]
The Coronavirus Pandemic and the Ethics of Triage | March 26, 2020
by R. J. Snell, Ph.D. This paper can be viewed as a pdf here: The Coronavirus Pandemic and the Ethics of Triage As the COVID-19 pandemic continues in Italy, many hospitals are overwhelmed with patients, necessitating difficult triage decisions that can seem like choosing who lives and who dies. In the United States, already […]
Pro-Life Topics for Lawmakers Regarding Coronavirus | March 25, 2020
This is Issue 43 in CLI’s On Point Series. To view this report as a PDF, see: On Point 43 Pro-Life Topics for Lawmakers Regarding Coronavirus. Abortion advocates have found a new ally—COVID-19. During this intensely stressful time, the vast majority of Americans are focused on protecting their health and the health of […]
A Policy and Funding Evaluation Of Human Fetal Tissue Research | September 11, 2020
This is Issue 2 in CLI’s On Science. To view this report as a PDF, see: A Policy and Funding Evaluation Of Human Fetal Tissue Research Background The body parts of preborn babies that die through the act of elective abortion are harvested and sold to desiring scientists for experimentation. These acts are heinous, […]
An Ethics Assessment of COVID-19 Vaccine Programs | May 6, 2020
Latest COVID-19 Vaccine Chart This is Issue 46 in CLI’s On Point Series. To view this report as a PDF, see: On Point 46: An Ethics Assessment of COVID-19 Vaccine Programs This page outlines the ethical considerations involved solely in vaccine production, based on information present at the time of publication. Subsequently, publication […]
Testimony of Dr. James Sherley, M.D., Ph.D. in Support of Missouri Bills regarding Humane Treatment of Aborted Fetal Remains | February 24, 2016
On February 23, the Missouri House Children and Families Committee heard five bills on issues stemming from the Center for Medical Progress’s undercover video exposé of Planned Parenthood, including: the sale and final disposition of aborted fetal remains, post-abortion tissue reporting requirements, and employee protections for whistleblowers.
Among those who testified in support of the bills was Dr. James Sherley, M.D., Ph.D., a physician scientist with expertise in biomedical research, cancer biology, and adult stem cell engineering. Dr. Sherley is founder and director of Asymmetrex, LLC, which develops new technologies for ethical adult stem cell medicine and drug discovery.